Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Resectable Localized Prostate Cancer 1Prostatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Plasma Cell 1Melanoma 1

Interventions

fludarabine 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2inebilizumab 1Sirolimus 1Positron-Emission Tomography 1Pemetrexed 1Lenalidomide 1Interleukin-6 1Hyperbaric Oxygenation 1Hydroxychloroquine 1Filgrastim 1Dexamethasone 1Bortezomib 1Blood Specimen Collection 113-valent pneumococcal vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasms, Plasma Cell × Hydroxychloroquine × Clear all
NCT01396200 2013-02-26

Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed
6 enrolled
Plasma cell

Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡